Inositol — usually myo-inositol — is a sugar alcohol that the body uses for intracellular signalling, particularly through what is called the phosphatidylinositol pathway. It plays roles in insulin sensitivity, neurotransmitter receptor function, and cell membrane biology. Inositol has a meaningful evidence base in obsessive-compulsive disorder, panic disorder, and polycystic ovary syndrome. The evidence in schizophrenia is much smaller and more cautious — and worth understanding accurately rather than overstated.
Inositol has reasonable evidence in OCD and panic, much weaker direct evidence in schizophrenia, and is best treated as experimental in this context.
What inositol is and does
Myo-inositol is the most common form in nature. It is found in fruits, beans, grains, and nuts and is also synthesised by the body. Inside cells, inositol is the building block for phosphatidylinositol, a class of molecules involved in:
- Signal transduction from many neurotransmitter receptors (including serotonin and muscarinic acetylcholine receptors)
- Insulin signalling
- Cell membrane structure
Lithium, a mood stabiliser used in bipolar and sometimes in schizoaffective disorder, partly works by depleting brain inositol pools — which is one reason researchers historically wondered whether inositol supplementation might affect mood and psychotic conditions.
The research outside schizophrenia
Inositol has been studied at high doses (typically 12–18 grams per day) in:
- Panic disorder — small randomised trials showed benefits comparable to fluvoxamine
- Obsessive-compulsive disorder — modest benefits in small trials
- Depression — mixed but mostly negative results
- Polycystic ovary syndrome — well-supported benefits at lower doses (2–4 grams)
The general profile that emerges is of a compound that may help with anxiety-spectrum and obsessive symptoms, with a clean safety record at high doses.
What the schizophrenia literature shows
The direct evidence in schizophrenia is sparse. A small randomised trial by Levine and colleagues (available via PubMed) tested 12 grams/day of inositol added to antipsychotic treatment in patients with chronic schizophrenia and found no significant overall benefit on psychotic symptoms. Other small reports have looked at inositol for tardive dyskinesia or for mood symptoms within schizophrenia and have produced largely negative or mixed results.
This is a case where the absence of strong positive evidence is itself the headline. Inositol has been studied. The studies have not shown meaningful effect on the core symptoms of schizophrenia at the doses tried.
Where inositol might still be relevant
- Co-occurring OCD or panic. Roughly 10–25% of people with schizophrenia have significant OCD symptoms and many have panic-like episodes. Inositol could plausibly help these symptoms even if it does not change psychosis.
- Antipsychotic-related metabolic dysfunction. Inositol's role in insulin signalling makes it of interest for the metabolic side effects of some antipsychotics, though the direct evidence in this context is preliminary.
- Reproductive concerns in PCOS. Some women with schizophrenia also have PCOS, where inositol has stronger evidence. This is a non-psychiatric reason a clinician might consider it.
Dosing and forms
Trials have used 12–18 grams per day of myo-inositol, usually in divided doses with food. It comes as a powder that dissolves in water with a slightly sweet taste. Some products combine myo-inositol with D-chiro-inositol in a 40:1 ratio (used mainly in PCOS). Lower doses (2–4 grams) are common in over-the-counter products but were not the doses used in psychiatric trials.
Tolerability and safety
Inositol is well tolerated. The most common side effects are mild gastrointestinal — gas, loose stools, nausea — particularly at higher doses. These usually settle with split dosing or food. There are no significant known interactions with antipsychotic medications.
People with bipolar disorder may experience activation or hypomania at high doses, since inositol's effects on cell signalling are in some ways opposite to those of lithium. Anyone with a mood disorder component (including schizoaffective disorder) should discuss with their prescriber before starting.
The honest bottom line
Inositol is not a treatment for schizophrenia. The published trials in this specific population have not shown clear benefit for psychotic symptoms, and the compound is much better characterised in OCD and panic. If you have schizophrenia plus prominent OCD or panic symptoms, inositol is one reasonable option to discuss with your prescriber — alongside conventional treatments for those conditions. If you have schizophrenia and are looking for a supplement to address the core symptoms, the evidence currently points more clearly toward N-acetylcysteine, omega-3 fatty acids, and addressing nutritional deficiencies than toward inositol.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.